|
|||||
|
|
A Phase I Dose-Escalation Trial of Trastuzumab and Alvespimycin Hydrochloride (KOS-1022; 17 DMAG) in the Treatment of Advanced Solid Tumors |
|
| Authors: | Jhaveri Komal Miller Kathy Rosen Lee Schneider Bryan Chap Linnea Hannah Alison Zhong Ziyang Ma Weining Hudis Clifford Modi Shanu |
| Affiliation: | Authors' Affiliations: Memorial Sloan-Kettering Cancer Center; Weill Cornell Medical College, New York, New York; Indianapolis Cancer Center, Indianapolis, Indiana; Premiere Oncology, Santa Monica; and Kosan Biosciences, Inc., Hayward, California; Acquired by Bristol-Myers Squibb in June 2008. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |